Streetbeat News

Price Targets

KMX

Truist Securities analyst Scot Ciccarelli has maintained a Hold rating on CarMax (NYSE:KMX) and increased the price target from $72 to $75.

Portfolio Pulse from Benzinga Newsdesk

December 22, 2023 | 2:41 pm

CTAS

JP Morgan analyst Andrew Steinerman has maintained an Overweight rating on Cintas (NASDAQ:CTAS) and increased the price target from $540 to $640.

Portfolio Pulse from Benzinga Newsdesk

December 22, 2023 | 2:41 pm

BSX

Truist Securities analyst Richard Newitter has reaffirmed a Buy rating on Boston Scientific (NYSE:BSX) and increased the price target from $59 to $66.

Portfolio Pulse from Benzinga Newsdesk

December 22, 2023 | 2:40 pm

ALVR

Piper Sandler analyst Christopher Raymond has downgraded AlloVir (NASDAQ:ALVR) from Overweight to Neutral and significantly reduced the price target from $27 to $1.5.

Portfolio Pulse from Benzinga Newsdesk

December 22, 2023 | 2:32 pm

CTAS

Cintas Corporation (NASDAQ:CTAS) reported Q2 FY24 sales of $2.38 billion, surpassing estimates and showing a 9.3% year-on-year growth. EPS was $3.61, beating the $3.49 consensus. Operating income rose 12.3% to $499.7 million, with operating margin up by 50 basis points to 21%. The company raised its FY24 revenue and EPS outlook, leading to a 6.6% increase in its stock price. Analysts from Stifel and RBC Capital revised their price targets for CTAS following the earnings report.

Portfolio Pulse from Avi Kapoor

December 22, 2023 | 2:32 pm

TSLA

RBC Capital analyst Tom Narayan has reiterated an Outperform rating on Tesla (NASDAQ:TSLA) and maintained a price target of $300.

Portfolio Pulse from Benzinga Newsdesk

December 22, 2023 | 2:15 pm

PAYX

RBC Capital analyst Ashish Sabadra has reiterated a 'Sector Perform' rating on Paychex (NASDAQ:PAYX) and maintained a price target of $130.

Portfolio Pulse from Benzinga Newsdesk

December 22, 2023 | 2:11 pm

CTAS

RBC Capital analyst Ashish Sabadra has reaffirmed an Outperform rating on Cintas (NASDAQ:CTAS) and increased the price target from $525 to $645.

Portfolio Pulse from Benzinga Newsdesk

December 22, 2023 | 2:06 pm

AXNX

Truist Securities analyst David Rescott has reaffirmed a Buy rating on Axonics (NASDAQ:AXNX) and increased the price target from $65 to $73, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

December 22, 2023 | 2:05 pm

AIR

Truist Securities analyst Michael Ciarmoli has maintained a Buy rating on AAR Corp (NYSE:AIR) and increased the price target from $68 to $81. The report was released on December 21, 2023.

Portfolio Pulse from Benzinga Newsdesk

December 22, 2023 | 2:03 pm